文献速递产科母胎医学

特别声明:评估产前先天性心脏病检出准确性的拟议质量指标

Special statement: Proposed quality metrics to assess accuracy of prenatal detection of congenital heart defects.
PubMed 文献 · Am J Obstet Gynecol · 2020-02-28

先天性心脏病是新生儿发病和死亡的主要原因,但产前检出率不足一半。本文基于2016年母胎医学会年会合作研讨会的建议,提出评估产前检出严重先天性心脏病(高发病率或死亡率、需手术或三级随访)的质量指标,包括回顾性(产后诊断病例是否产前识别)和前瞻性(产前超声与新生儿发现比较的灵敏度和特异度)两种方法,并讨论其应用、局限与挑战。

要点

  • 拟议指标包括回顾性和前瞻性两种,分别评估产后诊断病例的产前识别率和产前诊断的灵敏度和特异度。
  • 指标的未来发展需依赖ICD系统扩展及胎儿与新生儿记录链接系统的建立。

核心结论

  • 提出了评估产前严重先天性心脏病检出率的潜在质量指标,包括回顾性和前瞻性两种方法。

研究设计与样本

  • 基于2016年母胎医学会年会合作研讨会的建议,提出质量指标并讨论其应用、局限与挑战。

主要发现

  • 产前检出率不足一半,导致咨询、共同决策和合适机构分娩的机会丧失。
  • 回顾性指标评估产后诊断的先天性心脏病是否产前识别。
  • 前瞻性指标通过比较产前超声和新生儿发现评估产前诊断的灵敏度和特异度。

关键数值与推荐

  • 严重先天性心脏病定义为高发病率或死亡率、需手术或三级随访的缺陷。

临床怎么用

  • 可用于测量提供者、机构或人群层面的产前检出率,以支持质量改进。

局限性

  • 指标发展依赖于ICD系统扩展以区分胎儿和新生儿先天性心脏病编码,以及建立胎儿与新生儿记录链接系统。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Congenital heart defects are a leading cause of neonatal morbidity and mortality. Accurate prenatal diagnosis of congenital heart defects can reduce morbidity and mortality by improving prenatal care, facilitating predelivery pediatric cardiology consultation, and directing delivery to facilities with resources to manage the complex medical and surgical needs of newborns with congenital heart defects. Unfortunately, less than one half of congenital heart defect cases are detected prenatally, resulting in lost opportunities for counseling, shared decision-making, and delivery at an appropriate facility. Quality improvement initiatives to improve prenatal congenital heart defects detection depend on the ability to measure the rate of detection at the level of providers, facilities, or populations, but no standard metric exists for measuring the detection of congenital heart defects at any level. The need for such a metric was recognized at a Cooperative Workshop held at the 2016 Annual Meeting of the Society for Maternal-Fetal Medicine, which recommended the development of a quality metric to assess the rate of prenatal detection of clinically significant congenital heart defects. In this paper, we propose potential quality metrics to measure prenatal detection of critical congenital heart defects, defined as defects with a high rate of morbidity or mortality or that require surgery or tertiary follow-up. One metric is based on a retrospective approach, assessing whether postnatally diagnosed congenital heart defects had been identified prenatally. Other metrics are based on a prospective approach, assessing the sensitivity and specificity of prenatal diagnosis of congenital heart defects by comparing prenatal ultrasound findings with newborn findings. Potential applications, limitations, challenges, barriers, and value for both approaches are discussed. We conclude that future development of these metrics will depend on an expansion of the International Classification of Diseases system to include specific codes that distinguish fetal congenital heart defects from newborn congenital heart defects and on the development of record systems that facilitate the linkage of fetal records (in the maternal chart) with newborn records.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Combs CA, Hameed AB, Friedman AM, et al. Special statement: Proposed quality metrics to assess accuracy of prenatal detection of congenital heart defects. Am J Obstet Gynecol. 2020. PMID: 32114082. doi:10.1016/j.ajog.2020.02.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。